Cargando…

Neutralizing antibody titres in SARS-CoV-2 infections

The SARS-CoV-2 pandemic poses the greatest global public health challenge in a century. Neutralizing antibody is a correlate of protection and data on kinetics of virus neutralizing antibody responses are needed. We tested 293 sera from an observational cohort of 195 reverse transcription polymerase...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lau, Eric H. Y., Tsang, Owen T. Y., Hui, David S. C., Kwan, Mike Y. W., Chan, Wai-hung, Chiu, Susan S., Ko, Ronald L. W., Chan, Kin H., Cheng, Samuel M. S., Perera, Ranawaka A. P. M., Cowling, Benjamin J., Poon, Leo L. M., Peiris, Malik
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7782739/ https://www.ncbi.nlm.nih.gov/pubmed/33397909 http://dx.doi.org/10.1038/s41467-020-20247-4

Ejemplares similares

Evaluation of a SARS-CoV-2 Surrogate Virus Neutralization Test for Detection of Antibody in Human, Canine, Cat, and Hamster Sera
por: Perera, Ranawaka A. P. M., et al.
Publicado: (2021)

Long-term persistence of SARS-CoV-2 neutralizing antibody responses after infection and estimates of the duration of protection
por: Lau, Eric HY, et al.
Publicado: (2021)

Neutralizing antibody titres to SARS-CoV-2 Omicron variant and wild-type virus in those with past infection or vaccinated or boosted with mRNA BNT162b2 or inactivated CoronaVac vaccines
por: Peiris, Malik, et al.
Publicado: (2022)

Interim estimate of influenza vaccine effectiveness in hospitalised children, Hong Kong, 2017/18
por: Chiu, Susan S, et al.
Publicado: (2018)

SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection
por: Cohen, Carolyn A., et al.
Publicado: (2021)

Interim estimates of the effectiveness of influenza vaccination against influenza‐associated hospitalization in children in Hong Kong, 2015–16
por: Cowling, Benjamin J., et al.
Publicado: (2016)

SARS-CoV-2 Virus Culture and Subgenomic RNA for Respiratory Specimens from Patients with Mild Coronavirus Disease
por: Perera, Ranawaka A.P.M., et al.
Publicado: (2020)

Absence of MERS-Coronavirus in Bactrian Camels, Southern Mongolia, November 2014
por: Chan, Samuel M.S., et al.
Publicado: (2015)

A46 MERS-CoV in Arabian camels in Africa and Central Asia
por: Chu, Daniel K.W., et al.
Publicado: (2017)

Lack of Middle East Respiratory Syndrome Coronavirus Transmission from Infected Camels
por: Hemida, Maged G., et al.
Publicado: (2015)

Author Correction: ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection
por: Hachim, Asmaa, et al.
Publicado: (2020)

SARS-CoV-2 accessory proteins reveal distinct serological signatures in children
por: Hachim, Asmaa, et al.
Publicado: (2022)

Incidence of influenza A(H3N2) virus infections in Hong Kong in a longitudinal sero-epidemiological study, 2009-2015
por: Wei, Vivian W. I., et al.
Publicado: (2018)

Impact of host genetic polymorphisms on response to inactivated influenza vaccine in children
por: Tsang, Tim K., et al.
Publicado: (2023)

Lack of serological evidence of Middle East respiratory syndrome coronavirus infection in virus exposed camel abattoir workers in Nigeria, 2016
por: So, Ray TY, et al.
Publicado: (2018)

The Effects of Temperature and Relative Humidity on the Viability of the SARS Coronavirus
por: Chan, K. H., et al.
Publicado: (2011)

Stability of SARS-CoV-2 in different environmental conditions
por: Chin, Alex W H, et al.
Publicado: (2020)

MERS Coronavirus in Dromedary Camel Herd, Saudi Arabia
por: Hemida, Maged G., et al.
Publicado: (2014)

Immunogenicity of a Third Dose of BNT162b2 to Ancestral Severe Acute Respiratory Syndrome Coronavirus 2 and the Omicron Variant in Adults Who Received 2 Doses of Inactivated Vaccine
por: Leung, Nancy H L, et al.
Publicado: (2022)

Effects of Nonpharmaceutical COVID-19 Interventions on Pediatric Hospitalizations for Other Respiratory Virus Infections, Hong Kong
por: Chiu, Susan S., et al.
Publicado: (2022)

The effectiveness of influenza vaccination in preventing hospitalizations in children in Hong Kong, 2009–2013
por: Cowling, Benjamin J., et al.
Publicado: (2014)

Reconstructing antibody dynamics to estimate the risk of influenza virus infection
por: Tsang, Tim K., et al.
Publicado: (2022)

Author Correction: Reconstructing antibody dynamics to estimate the risk of influenza virus infection
por: Tsang, Tim K., et al.
Publicado: (2023)

Lung pathology of fatal severe acute respiratory syndrome
por: Nicholls, John M, et al.
Publicado: (2003)

Serological assays for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), March 2020
por: Perera, Ranawaka APM, et al.
Publicado: (2020)

Serum anti-neuraminidase antibody responses in human influenza A(H1N1)pdm09 virus infections
por: Karunarathna, Herath M. T. K., et al.
Publicado: (2019)

Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures
por: Hui, Kenrie P Y, et al.
Publicado: (2020)

The SARS-CoV-2 antibody landscape is lower in magnitude for structural proteins, diversified for accessory proteins and stable long-term in children
por: Hachim, Asmaa, et al.
Publicado: (2021)

Effects of School Closures, 2008 Winter Influenza Season, Hong Kong
por: Cowling, Benjamin J., et al.
Publicado: (2008)

Relative incidence and individual-level severity of seasonal influenza A H3N2 compared with 2009 pandemic H1N1
por: Kwok, Kin On, et al.
Publicado: (2017)

Host DNA released by NETosis in neutrophils exposed to seasonal H1N1 and highly pathogenic H5N1 influenza viruses
por: Chan, Louisa L. Y., et al.
Publicado: (2020)

Probable Transmission of SARS-CoV-2 Omicron Variant in Quarantine Hotel, Hong Kong, China, November 2021
por: Gu, Haogao, et al.
Publicado: (2022)

Loop-Mediated Isothermal Amplification for Influenza A (H5N1) Virus
por: Jayawardena, Shanthi, et al.
Publicado: (2007)

Determining Existing Human Population Immunity as Part of Assessing Influenza Pandemic Risk
por: Cheung, Jonathan Tin Lai, et al.
Publicado: (2022)

SARS-CoV-2 specific T cell responses are lower in children and increase with age and time after infection
por: Cohen, Carolyn A, et al.
Publicado: (2021)

High-throughput analysis of anti-poliovirus neutralization antibody titre in human serum by the pseudovirus neutralization test
por: Arita, Minetaro, et al.
Publicado: (2022)

Variation by lineage in serum antibody responses to influenza B virus infections
por: Lau, Yiu Chung, et al.
Publicado: (2020)

Heterosubtypic Protection Induced by a Live Attenuated Influenza Virus Vaccine Expressing Galactose-α-1,3-Galactose Epitopes in Infected Cells
por: Yan, Li-Meng, et al.
Publicado: (2020)

Indirect protection from vaccinating children against influenza in households
por: Tsang, Tim K., et al.
Publicado: (2019)

Cross-reactive antibody response between SARS-CoV-2 and SARS-CoV infections
por: Lv, Huibin, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3rc72n0knt4ut1r7bbsuo0uqc0